Click here to get full coverage on A Look At InMode (INMD) Valuation After New 2025 And 2026 Revenue Guidance - Yahoo Finance

A Look At InMode (INMD) Valuation After New 2025 And 2026 Revenue Guidance  Yahoo Finance

A Look At InMode (INMD) Valuation After New 2025 And 2026 Revenue Guidance - Yahoo Finance

Click here to get full coverage on Assessing InMode (INMD) Valuation After Fresh 2025 And 2026 Earnings Guidance - simplywall.st

Assessing InMode (INMD) Valuation After Fresh 2025 And 2026 Earnings Guidance  simplywall.st

Assessing InMode (INMD) Valuation After Fresh 2025 And 2026 Earnings Guidance - simplywall.st

Click here to get full coverage on Behavioral Patterns of INMD and Institutional Flows - Stock Traders Daily

Behavioral Patterns of INMD and Institutional Flows  Stock Traders Daily

Behavioral Patterns of INMD and Institutional Flows - Stock Traders Daily

Click here to get full coverage on InMode: Discounted Valuation And Strong Fundamentals Make It A Buy (INMD) - Seeking Alpha

InMode: Discounted Valuation And Strong Fundamentals Make It A Buy (INMD)  Seeking Alpha

InMode: Discounted Valuation And Strong Fundamentals Make It A Buy (INMD) - Seeking Alpha

Click here to get full coverage on INMD Stock Draws Investor Attention On Q4 Financial Update - Stocktwits

INMD Stock Draws Investor Attention On Q4 Financial Update  Stocktwits

INMD Stock Draws Investor Attention On Q4 Financial Update - Stocktwits

Click here to get full coverage on Inmode Ltd (INMD): Is This Deeply Undervalued Stock a Hidden Gem? - The Acquirer's Multiple

Inmode Ltd (INMD): Is This Deeply Undervalued Stock a Hidden Gem?  The Acquirer's Multiple

Inmode Ltd (INMD): Is This Deeply Undervalued Stock a Hidden Gem? - The Acquirer's Multiple

Click here to get full coverage on InMode (NASDAQ:INMD) Could Be Struggling To Allocate Capital - Sahm

InMode (NASDAQ:INMD) Could Be Struggling To Allocate Capital  Sahm

InMode (NASDAQ:INMD) Could Be Struggling To Allocate Capital - Sahm

Click here to get full coverage on InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M - Fidelity

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M  Fidelity

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M - Fidelity

Click here to get full coverage on InMode (NASDAQ:INMD) shareholders have endured a 59% loss from investing in the stock three years ago - Yahoo Finance

InMode (NASDAQ:INMD) shareholders have endured a 59% loss from investing in the stock three years ago  Yahoo Finance

InMode (NASDAQ:INMD) shareholders have endured a 59% loss from investing in the stock three years ago - Yahoo Finance

Click here to get full coverage on InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by Brokerages  MarketBeat

InMode Ltd. (NASDAQ:INMD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Click here to get full coverage on Updated 2025–2026 Revenue Guidance Might Change The Case For Investing In InMode (INMD) - simplywall.st

Updated 2025–2026 Revenue Guidance Might Change The Case For Investing In InMode (INMD)  simplywall.st

Updated 2025–2026 Revenue Guidance Might Change The Case For Investing In InMode (INMD) - simplywall.st

Click here to get full coverage on InMode (INMD) Net Margin Beat Reinforces Bullish Value Narrative After 19.8% Earnings Growth - Yahoo Finance

InMode (INMD) Net Margin Beat Reinforces Bullish Value Narrative After 19.8% Earnings Growth  Yahoo Finance

InMode (INMD) Net Margin Beat Reinforces Bullish Value Narrative After 19.8% Earnings Growth - Yahoo Finance

Click here to get full coverage on InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  Yahoo Finance

InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on InMode Ltd. (NASDAQ:INMD) is favoured by institutional owners who hold 58% of the company - Yahoo Finance

InMode Ltd. (NASDAQ:INMD) is favoured by institutional owners who hold 58% of the company  Yahoo Finance

InMode Ltd. (NASDAQ:INMD) is favoured by institutional owners who hold 58% of the company - Yahoo Finance

Click here to get full coverage on What To Expect From InMode Ltd (INMD) Q3 2025 Earnings - Yahoo Finance

What To Expect From InMode Ltd (INMD) Q3 2025 Earnings  Yahoo Finance

What To Expect From InMode Ltd (INMD) Q3 2025 Earnings - Yahoo Finance

Click here to get full coverage on Can InMode’s (INMD) Steady Guidance Reveal New Clues About Its Management Credibility? - Yahoo Finance

Can InMode’s (INMD) Steady Guidance Reveal New Clues About Its Management Credibility?  Yahoo Finance

Can InMode’s (INMD) Steady Guidance Reveal New Clues About Its Management Credibility? - Yahoo Finance

Click here to get full coverage on Did DOMA Perpetual’s Push for Major Buybacks Just Shift InMode’s (INMD) Investment Narrative? - Yahoo Finance

Did DOMA Perpetual’s Push for Major Buybacks Just Shift InMode’s (INMD) Investment Narrative?  Yahoo Finance

Did DOMA Perpetual’s Push for Major Buybacks Just Shift InMode’s (INMD) Investment Narrative? - Yahoo Finance

Click here to get full coverage on We Think That There Are More Issues For InMode (NASDAQ:INMD) Than Just Sluggish Earnings - Yahoo Finance

We Think That There Are More Issues For InMode (NASDAQ:INMD) Than Just Sluggish Earnings  Yahoo Finance

We Think That There Are More Issues For InMode (NASDAQ:INMD) Than Just Sluggish Earnings - Yahoo Finance

Click here to get full coverage on InMode (INMD) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

InMode (INMD) Q2 Earnings and Revenues Beat Estimates  Yahoo Finance

InMode (INMD) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

Click here to get full coverage on Assessing InMode (INMD) Valuation as Shareholder Activism Escalates Over Buyback Push - Yahoo Finance

Assessing InMode (INMD) Valuation as Shareholder Activism Escalates Over Buyback Push  Yahoo Finance

Assessing InMode (INMD) Valuation as Shareholder Activism Escalates Over Buyback Push - Yahoo Finance

Click here to get full coverage on How Softer Q3 Results and Leadership Changes at InMode (INMD) Have Changed Its Investment Story - simplywall.st

How Softer Q3 Results and Leadership Changes at InMode (INMD) Have Changed Its Investment Story  simplywall.st

How Softer Q3 Results and Leadership Changes at InMode (INMD) Have Changed Its Investment Story - simplywall.st

Click here to get full coverage on InMode (NASDAQ:INMD) Trading Down 8.4% - What's Next? - MarketBeat

InMode (NASDAQ:INMD) Trading Down 8.4% - What's Next?  MarketBeat

InMode (NASDAQ:INMD) Trading Down 8.4% - What's Next? - MarketBeat

Click here to get full coverage on InMode’s Shares Look Cheap—But Caution Remains For 2025 - Finimize

InMode’s Shares Look Cheap—But Caution Remains For 2025  Finimize

InMode’s Shares Look Cheap—But Caution Remains For 2025 - Finimize

Click here to get full coverage on Integration of CRISPR-Cas9 screens and multi-omics profiling reveals chromodomain helicase DNA binding protein 7-angiopoietin-1 as a novel multidrug resistance axis in acute myeloid leukemia - Wiley Online Library

Integration of CRISPR-Cas9 screens and multi-omics profiling reveals chromodomain helicase DNA binding protein 7-angiopoietin-1 as a novel multidrug resistance axis in acute myeloid leukemia  Wiley Online Library

Integration of CRISPR-Cas9 screens and multi-omics profiling reveals chromodomain helicase DNA binding protein 7-angiopoietin-1 as a novel multidrug resistance axis in acute myeloid leukemia - Wiley Online Library

Click here to get full coverage on InMode (NASDAQ:INMD) Shares Pass Above 200 Day Moving Average - Should You Sell? - MarketBeat

InMode (NASDAQ:INMD) Shares Pass Above 200 Day Moving Average - Should You Sell?  MarketBeat

InMode (NASDAQ:INMD) Shares Pass Above 200 Day Moving Average - Should You Sell? - MarketBeat

Click here to get full coverage on InMode (INMD) Profit Margin Surges to 44.5%, Reinforcing Bullish Narratives on Value and Growth - simplywall.st

InMode (INMD) Profit Margin Surges to 44.5%, Reinforcing Bullish Narratives on Value and Growth  simplywall.st

InMode (INMD) Profit Margin Surges to 44.5%, Reinforcing Bullish Narratives on Value and Growth - simplywall.st

Click here to get full coverage on ICE agents involved in MD shooting that injures two people - Maryland Daily Record

ICE agents involved in MD shooting that injures two people  Maryland Daily Record

ICE agents involved in MD shooting that injures two people - Maryland Daily Record

Click here to get full coverage on InMode Appoints Michael Dennison as President of North America - PR Newswire

InMode Appoints Michael Dennison as President of North America  PR Newswire

InMode Appoints Michael Dennison as President of North America - PR Newswire

Click here to get full coverage on InMode to Participate in Upcoming Investor Conferences - PR Newswire

InMode to Participate in Upcoming Investor Conferences  PR Newswire

InMode to Participate in Upcoming Investor Conferences - PR Newswire

Click here to get full coverage on $510M Cash Hoard: Activist Investor Pushes InMode to Launch Massive 20% Share Buyback Program - Stock Titan

$510M Cash Hoard: Activist Investor Pushes InMode to Launch Massive 20% Share Buyback Program  Stock Titan

$510M Cash Hoard: Activist Investor Pushes InMode to Launch Massive 20% Share Buyback Program - Stock Titan

Click here to get full coverage on Investors Don't See Light At End Of InMode Ltd.'s (NASDAQ:INMD) Tunnel And Push Stock Down 25% - simplywall.st

Investors Don't See Light At End Of InMode Ltd.'s (NASDAQ:INMD) Tunnel And Push Stock Down 25%  simplywall.st

Investors Don't See Light At End Of InMode Ltd.'s (NASDAQ:INMD) Tunnel And Push Stock Down 25% - simplywall.st

Click here to get full coverage on InMode (NASDAQ: INMD) schedules UBS, Jefferies and Canaccord investor events in November - Stock Titan

InMode (NASDAQ: INMD) schedules UBS, Jefferies and Canaccord investor events in November  Stock Titan

InMode (NASDAQ: INMD) schedules UBS, Jefferies and Canaccord investor events in November - Stock Titan

Click here to get full coverage on International Growth May Drive InMode's Come-Back, But Not Just Yet (Hold For Now) (NASDAQ:INMD) - Seeking Alpha

International Growth May Drive InMode's Come-Back, But Not Just Yet (Hold For Now) (NASDAQ:INMD)  Seeking Alpha

International Growth May Drive InMode's Come-Back, But Not Just Yet (Hold For Now) (NASDAQ:INMD) - Seeking Alpha

Click here to get full coverage on InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease - PR Newswire

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease  PR Newswire

InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease - PR Newswire

Click here to get full coverage on Barclays Maintains InMode(INMD.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Barclays Maintains InMode(INMD.US) With Buy Rating, Maintains Target Price $21  富途牛牛

Barclays Maintains InMode(INMD.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛

Click here to get full coverage on EV Market: Will INMD benefit from geopolitical trends - Exit Point & Daily Oversold Bounce Ideas - baoquankhu1.vn

EV Market: Will INMD benefit from geopolitical trends - Exit Point & Daily Oversold Bounce Ideas  baoquankhu1.vn

EV Market: Will INMD benefit from geopolitical trends - Exit Point & Daily Oversold Bounce Ideas - baoquankhu1.vn

Click here to get full coverage on InMode: Margin Pressure, But Optionality Makes It Worth A Look (NASDAQ:INMD) - Seeking Alpha

InMode: Margin Pressure, But Optionality Makes It Worth A Look (NASDAQ:INMD)  Seeking Alpha

InMode: Margin Pressure, But Optionality Makes It Worth A Look (NASDAQ:INMD) - Seeking Alpha

Click here to get full coverage on Squarepoint Ops LLC Has $2.08 Million Stake in InMode Ltd. $INMD - MarketBeat

Squarepoint Ops LLC Has $2.08 Million Stake in InMode Ltd. $INMD  MarketBeat

Squarepoint Ops LLC Has $2.08 Million Stake in InMode Ltd. $INMD - MarketBeat

Click here to get full coverage on Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) - Finviz

Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD)  Finviz

Canaccord Genuity Maintains a Hold Rating on InMode Ltd. (INMD) - Finviz

Click here to get full coverage on Oxidative phosphorylation at the crossroads of cancer: Metabolic orchestration, stromal collusion, and emerging therapeutic horizons - Wiley Online Library

Oxidative phosphorylation at the crossroads of cancer: Metabolic orchestration, stromal collusion, and emerging therapeutic horizons  Wiley Online Library

Oxidative phosphorylation at the crossroads of cancer: Metabolic orchestration, stromal collusion, and emerging therapeutic horizons - Wiley Online Library

Click here to get full coverage on InMode to Present at Baird 2025 Global Healthcare Conference - PR Newswire

InMode to Present at Baird 2025 Global Healthcare Conference  PR Newswire

InMode to Present at Baird 2025 Global Healthcare Conference - PR Newswire

Click here to get full coverage on Message from Norman Rosenblum, INMD Scientific Director - cihr-irsc.gc.ca

Message from Norman Rosenblum, INMD Scientific Director  cihr-irsc.gc.ca

Message from Norman Rosenblum, INMD Scientific Director - cihr-irsc.gc.ca

Click here to get full coverage on InMode Ltd (NASDAQ:INMD) Reports Mixed Q2 2025 Results: Revenue Miss but EPS Beat Drives Pre-Market Gains - Chartmill

InMode Ltd (NASDAQ:INMD) Reports Mixed Q2 2025 Results: Revenue Miss but EPS Beat Drives Pre-Market Gains  Chartmill

InMode Ltd (NASDAQ:INMD) Reports Mixed Q2 2025 Results: Revenue Miss but EPS Beat Drives Pre-Market Gains - Chartmill

Click here to get full coverage on Morgan State leads growth of HBCU economic impact in MD - Maryland Daily Record

Morgan State leads growth of HBCU economic impact in MD  Maryland Daily Record

Morgan State leads growth of HBCU economic impact in MD - Maryland Daily Record

Click here to get full coverage on Changes AHEAD in MD’s Health Care Model? - Maryland Association of Counties

Changes AHEAD in MD’s Health Care Model?  Maryland Association of Counties

Changes AHEAD in MD’s Health Care Model? - Maryland Association of Counties

Click here to get full coverage on Why INMD stock could benefit from AI revolution - July 2025 Trends & Technical Pattern Based Signals - Улправда

Why INMD stock could benefit from AI revolution - July 2025 Trends & Technical Pattern Based Signals  Улправда

Why INMD stock could benefit from AI revolution - July 2025 Trends & Technical Pattern Based Signals - Улправда

Click here to get full coverage on A Look At The Intrinsic Value Of InMode Ltd. (NASDAQ:INMD) - 富途牛牛

A Look At The Intrinsic Value Of InMode Ltd. (NASDAQ:INMD)  富途牛牛

A Look At The Intrinsic Value Of InMode Ltd. (NASDAQ:INMD) - 富途牛牛

Click here to get full coverage on InMode: A Clear Bargain With Unique Risks (NASDAQ:INMD) - Seeking Alpha

InMode: A Clear Bargain With Unique Risks (NASDAQ:INMD)  Seeking Alpha

InMode: A Clear Bargain With Unique Risks (NASDAQ:INMD) - Seeking Alpha

Click here to get full coverage on CCORF Maintains InMode(INMD.US) With Hold Rating, Raises Target Price to $16 - 富途牛牛

CCORF Maintains InMode(INMD.US) With Hold Rating, Raises Target Price to $16  富途牛牛

CCORF Maintains InMode(INMD.US) With Hold Rating, Raises Target Price to $16 - 富途牛牛

Click here to get full coverage on TR | OpenAI - 4o Maintains InMode(INMD.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛

TR | OpenAI - 4o Maintains InMode(INMD.US) With Buy Rating, Raises Target Price to $16  富途牛牛

TR | OpenAI - 4o Maintains InMode(INMD.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛

Click here to get full coverage on Needham Maintains InMode(INMD.US) With Hold Rating - 富途牛牛

Needham Maintains InMode(INMD.US) With Hold Rating  富途牛牛

Needham Maintains InMode(INMD.US) With Hold Rating - 富途牛牛

Click here to get full coverage on Barclays Maintains InMode(INMD.US) With Buy Rating, Cuts Target Price to $21 - 富途牛牛

Barclays Maintains InMode(INMD.US) With Buy Rating, Cuts Target Price to $21  富途牛牛

Barclays Maintains InMode(INMD.US) With Buy Rating, Cuts Target Price to $21 - 富途牛牛

Click here to get full coverage on Insider Trends: Will INMD stock continue upward momentum - July 2025 Catalysts & Long-Term Growth Plans - Bộ Nội Vụ

Insider Trends: Will INMD stock continue upward momentum - July 2025 Catalysts & Long-Term Growth Plans  Bộ Nội Vụ

Insider Trends: Will INMD stock continue upward momentum - July 2025 Catalysts & Long-Term Growth Plans - Bộ Nội Vụ

Click here to get full coverage on Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - Yahoo Finance

Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?  Yahoo Finance

Why Is InMode Ltd. (INMD) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - Yahoo Finance

Click here to get full coverage on With 57% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big guns - Yahoo Finance

With 57% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big guns  Yahoo Finance

With 57% institutional ownership, InMode Ltd. (NASDAQ:INMD) is a favorite amongst the big guns - Yahoo Finance

Click here to get full coverage on Small extracellular vesicles: Yields, functionalization and applications in diabetic wound management - Wiley Online Library

Small extracellular vesicles: Yields, functionalization and applications in diabetic wound management  Wiley Online Library

Small extracellular vesicles: Yields, functionalization and applications in diabetic wound management - Wiley Online Library

Click here to get full coverage on Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges - Wiley Online Library

Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges  Wiley Online Library

Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges - Wiley Online Library

Click here to get full coverage on Immune function assessing of TIM3/CD28-modified CD19 CAR-T cells and general CD19 CAR-T cells through a high-throughput single-cell microarray platform - Wiley Online Library

Immune function assessing of TIM3/CD28-modified CD19 CAR-T cells and general CD19 CAR-T cells through a high-throughput single-cell microarray platform  Wiley Online Library

Immune function assessing of TIM3/CD28-modified CD19 CAR-T cells and general CD19 CAR-T cells through a high-throughput single-cell microarray platform - Wiley Online Library

Click here to get full coverage on Theranostic applications of biomolecule-responsive aggregation-induced emission luminogens - Wiley Online Library

Theranostic applications of biomolecule-responsive aggregation-induced emission luminogens  Wiley Online Library

Theranostic applications of biomolecule-responsive aggregation-induced emission luminogens - Wiley Online Library

Click here to get full coverage on Nanoparticles derived from herbal preparations May represent a novel nucleic acid therapy - Wiley Online Library

Nanoparticles derived from herbal preparations May represent a novel nucleic acid therapy  Wiley Online Library

Nanoparticles derived from herbal preparations May represent a novel nucleic acid therapy - Wiley Online Library

Click here to get full coverage on Why Are Analysts Bullish on InMode Ltd. (INMD) Right Now? - Yahoo Finance

Why Are Analysts Bullish on InMode Ltd. (INMD) Right Now?  Yahoo Finance

Why Are Analysts Bullish on InMode Ltd. (INMD) Right Now? - Yahoo Finance

Click here to get full coverage on Engineered oncolytic bacteria for malignant solid tumor treatment - Wang - 2024 - Interdisciplinary Medicine - Wiley Online Library

Engineered oncolytic bacteria for malignant solid tumor treatment - Wang - 2024 - Interdisciplinary Medicine  Wiley Online Library

Engineered oncolytic bacteria for malignant solid tumor treatment - Wang - 2024 - Interdisciplinary Medicine - Wiley Online Library

Click here to get full coverage on InMode Stock (NASDAQ:INMD): 2 Catalysts That Can Send Shares Skyrocketing - Yahoo Finance

InMode Stock (NASDAQ:INMD): 2 Catalysts That Can Send Shares Skyrocketing  Yahoo Finance

InMode Stock (NASDAQ:INMD): 2 Catalysts That Can Send Shares Skyrocketing - Yahoo Finance

Click here to get full coverage on Anti-angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application - Wiley Online Library

Anti-angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application  Wiley Online Library

Anti-angiogenic therapy enhances cancer immunotherapy: Mechanism and clinical application - Wiley Online Library

Click here to get full coverage on InMode Stock: An Inverse Bubble Caused By Short-Term Trouble - Seeking Alpha

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble  Seeking Alpha

InMode Stock: An Inverse Bubble Caused By Short-Term Trouble - Seeking Alpha

Click here to get full coverage on Eva Longoria Announced as InMode Global Brand Ambassador - PR Newswire

Eva Longoria Announced as InMode Global Brand Ambassador  PR Newswire

Eva Longoria Announced as InMode Global Brand Ambassador - PR Newswire

Click here to get full coverage on InMode (INMD) Q2 2024 Earnings Call Transcript - The Motley Fool

InMode (INMD) Q2 2024 Earnings Call Transcript  The Motley Fool

INMD

Price Chart

Key Statistics

Technicals

About INMD

Latest News

A Look At InMode (INMD) Valuation After New 2025 And 2026 Revenue Guidance - Yahoo Finance

Assessing InMode (INMD) Valuation After Fresh 2025 And 2026 Earnings Guidance - simplywall.st

Behavioral Patterns of INMD and Institutional Flows - Stock Traders Daily

Advanced Charts

Top Gainers

Top Losers